Leading Scarlet Fever Companies in Vietnam | Leaders 2026

Leading Scarlet Fever Companies in Vietnam

The following is a data-backed list of the leading Vietnam Scarlet Fever companies, compiled through 6Wresearch's proprietary research and validated by in-house industry analysts. These companies represent the key players shaping competition in the Vietnam Scarlet Fever Industry, including Ministry of Health (MOH), World Health Organization (WHO), and other established names.

List of Scarlet Fever companies in Vietnam:

1. Ministry of Health (MOH)

Oversees national infectious disease policies, surveillance systems, and public health programs related to bacterial infections.

2. World Health Organization (WHO)

Provides global clinical guidance, disease management recommendations, and antimicrobial stewardship support for infectious diseases.

3. Sanofi

Supports infectious disease management through healthcare solutions, pharmaceutical expertise, and therapies used across bacterial disease treatment areas.

4. GSK Vietnam

Develops healthcare solutions focused on infectious diseases, vaccines, and medicines supporting respiratory and bacterial infection care.

5. DHG Pharmaceutical Joint Stock Company

A major Vietnamese pharmaceutical company involved in essential medicines and treatment solutions for common infectious conditions.

6. Traphaco Joint Stock Company

Provides pharmaceutical products and healthcare solutions supporting disease treatment and patient care across Vietnam.

7. Imexpharm Corporation

Focuses on high-quality pharmaceutical formulations, including antibiotic-related therapies used in infectious disease management.

8. Domesco Medical Import Export Joint Stock Corporation

Contributes to Vietnam’s healthcare sector through pharmaceutical products supporting treatment of bacterial and community-acquired infections.

9. Pymepharco Joint Stock Company

Specializes in pharmaceutical development with a portfolio covering antibiotics and other essential therapeutic categories.

10. Mediplantex National Pharmaceutical Joint Stock Company

Engages in pharmaceutical production and healthcare solutions supporting treatment needs in infectious disease segments.

Frequently Asked Questions About the Market Study (FAQs):